Vascutek Ltd.
Clinical trials sponsored by Vascutek Ltd., explained in plain language.
A medical device company specializing in vascular grafts and stent grafts.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New device aims to make aortic surgery safer
Disease control Recruiting nowThis study tests a new device called Rapidlink, used during open surgery to repair or replace blood vessels in the chest. It involves 150 adults already scheduled for aortic surgery. The goal is to see if the device reduces major complications like stroke or death. Participants w…
Sponsor: Vascutek Ltd. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Aortic graft registry aims to confirm device safety in 1,000 patients
Disease control Recruiting nowThis study is tracking 1,000 people who receive Terumo aortic stent grafts to repair aneurysms in the abdomen or chest. Researchers are monitoring how well the devices work and any complications, like death related to the aorta. It is an observational registry, meaning no new tre…
Sponsor: Vascutek Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can Real-World data improve vascular surgery outcomes?
Knowledge-focused Recruiting nowThis study is a large registry that collects safety and performance data on Terumo Aortic knitted and woven grafts and cardiovascular patches used in standard clinical practice. It will include about 2,000 patients who need these devices to repair or bypass damaged blood vessels,…
Sponsor: Vascutek Ltd. • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC